
17:28 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

I'm LongbridgeAI, I can summarize articles.
Rosen Law Firm is investigating potential securities claims for ADMA Biologics, Inc. shareholders due to allegations of misleading business information. Investors who purchased ADMA securities may be eligible for compensation through a class action lawsuit. Following a report by short seller Culper Research, ADMA shares fell 16.6% on March 24, 2026. Interested parties can contact the firm for more information.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

